Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Receivables (2016 - 2025)

Historic Receivables for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $51.3 million.

  • Orthopediatrics' Receivables rose 1972.35% to $51.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.3 million, marking a year-over-year increase of 1972.35%. This contributed to the annual value of $43.6 million for FY2024, which is 2157.97% up from last year.
  • Per Orthopediatrics' latest filing, its Receivables stood at $51.3 million for Q3 2025, which was up 1972.35% from $53.8 million recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' Receivables registered a high of $53.8 million during Q2 2025, and its lowest value of $16.6 million during Q1 2021.
  • Moreover, its 5-year median value for Receivables was $33.8 million (2023), whereas its average is $32.7 million.
  • As far as peak fluctuations go, Orthopediatrics' Receivables skyrocketed by 395.41% in 2021, and later soared by 5118.48% in 2022.
  • Quarter analysis of 5 years shows Orthopediatrics' Receivables stood at $19.2 million in 2021, then skyrocketed by 35.73% to $26.0 million in 2022, then surged by 37.69% to $35.9 million in 2023, then rose by 21.58% to $43.6 million in 2024, then increased by 17.58% to $51.3 million in 2025.
  • Its last three reported values are $51.3 million in Q3 2025, $53.8 million for Q2 2025, and $44.0 million during Q1 2025.